Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026) Certified by Founder
Lodge
Outrun Therapeutics
start up
United Kingdom
- Dundee, Scotland
- 19/04/2024
- Seed
- $10,000,000
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
- Industry Biotechnology Research
- Website https://outruntx.com/
- LinkedIn https://www.linkedin.com/company/outrun-therapeutics/
Related People
Carolyn PorterFounder
United Kingdom -
Greater Oxford Area
25 years of leadership experience, including in the spin-out arena, having led the formation of 16 companies raising £52M cumulatively in seed financing while at Oxford University. Held Board positions in several biotech companies and formerly held Business Development roles in big pharma (Novartis) and big biotech(Chiron).
Specialties: Key skills include business development, deal negotiation and execution, strategic, market and business analysis, people management and project management.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)